Tagged with Biotech

Taiwan Dr Hardy Chan shares the story of how he came out of retirement to lead Allianz Pharmascience; an up-and-coming biotech which aims to meet the unmet medical needs of rare disease patients, particularly in Asia. Dr Chan delves deep into the innovative science behind the company’s pipeline and shares the…

China Dr Shuqian Jing, founder, Chairman and CEO of Gmax Biopharm, an innovative biotech company headquartered in Hangzhou, shares how his experiences at global biopharma companies like BMS and Amgen inspired him to create his own biotech company; Gmax’s focus on G protein-coupled receptor (GPCR) therapeutic antibodies; the exciting pipeline the…

Puerto Rico Dr Federico Goodsaid, CEO of Puerto Rico’s first biopharmaceutical start-up MBQ Pharma, has previously worked at Vertex Pharmaceuticals and TOMA Biosciences and is considered an expert in regulatory affairs. Here, he highlights the encouraging results MBQ Pharma has achieved in preclinical efficacy and safety trials and acknowledges the backing the…

China Serial entrepreneur and Ronnsi CEO Yiming Yao discusses the inspiration behind the company’s formation, its unique specialization in ovine heparin, and his strategy to take the firm to the next level globally.   Currently, I believe that we might be the only company in the world working in the area…

Biotech China’s rapidly-growing biotech sector is increasingly hungry for preclinical drug candidates to commercialise in China, and Chinese companies are spending top dollar for cutting-edge technology from the US and UK. Despite mounting US-China tensions in the life sciences, the demand remains strong for cross-border licensing deals, which are raising drug…

Biotech Taiwan has long been a leader in biotechnology research and development. With the government’s emphasis on higher education and research, Taiwan has trained a diverse pool of talent in the scientific and technical fields, which is what is required to drive innovation in multidisciplinary biomedical research. PwC estimated that biotech…

USA Eurasia Group’s Aditya Bhattacharji looks at the potentially damaging fallout of the ongoing US-China trade war on the life sciences industry.   Biotech [is the] new frontier for US-China tensions The G20 gathering in Osaka at the end of June was, overall, less tense than other multilateral fora over the…

Biotech With a strong research base formed around the Karolinska Institute and Uppsala University, Sweden has grown to be one of Europe’s premier biotech hotspots. Several companies spun out of research conducted at these institutes and others are now listed on the Stockholm stock exchange and already have products on the…

China Dr Jiang Lei and Dr Shou Jianyong, EnnovaBio’s co-founders, introduce their strategy and outline the progress being made in the Chinese biopharma industry at large.   We are a Chinese company so we really want to benefit Chinese patients and meet unmet medical needs in China. Otherwise, why would we…

Taiwan Dr Jan-Mou Lee, founder of FullHope Biomedical, shares his story of how he came to establish his company after a realization about the loss of impact that occurs when critical research is never transferred outside of the laboratory. Dr Lee goes on to explain his Full Hope’s revolutionary platform that…

Taiwan Dr Tse Wen Chang, founder of Immunwork, gives an update on the preclinical development process of the company’s revolutionary T-E pharmaceutical products and goes on to give his expert insights on the dynamics at play within Taiwan’s biotech and biomedical industries.   Whether Taiwan’s biomedical industry can be robust will…

Sweden SwedenBIO gathers together actors from across the life science ecosystem of Sweden, with members ranging from small university spin-offs to large international companies, incubators, science parks, patent bureaus, and funding bodies. Jonas Ekstrand and Helena Strigård outline what makes Sweden such an innovation powerhouse, how SwedenBIO has fostered international connections,…